Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1967 Mar;29(3):367–377. doi: 10.1111/j.1476-5381.1967.tb01968.x

The detection and estimation of bradykinin in the circulating blood.

S H Ferreira, J R Vane
PMCID: PMC1557222  PMID: 4382328

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERALDO W. T. Formation of bradykinin in anaphylactic and peptone shock. Am J Physiol. 1950 Nov;163(2):283–289. doi: 10.1152/ajplegacy.1950.163.2.283. [DOI] [PubMed] [Google Scholar]
  2. DINIZ C. R., CARVALHO I. F. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963 Feb 4;104:77–89. doi: 10.1111/j.1749-6632.1963.tb17654.x. [DOI] [PubMed] [Google Scholar]
  3. FELDBERG W., LEWIS G. P. THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN. J Physiol. 1964 May;171:98–108. doi: 10.1113/jphysiol.1964.sp007364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FOX R. H., HILTON S. M. Bradykinin formation in human skin as a factor in heat vasodilatation. J Physiol. 1958 Jul 14;142(2):219–232. doi: 10.1113/jphysiol.1958.sp006011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GADDUM J. H. The technique of superfusion. Br J Pharmacol Chemother. 1953 Sep;8(3):321–326. doi: 10.1111/j.1476-5381.1953.tb00801.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HILTON S. M., LEWIS G. P. The relationship between glandular activity, bradykinin formation and functional vasodilatation in the submandibular salivary gland. J Physiol. 1956 Nov 28;134(2):471–483. doi: 10.1113/jphysiol.1956.sp005658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HORTON E. W. Human urinary kinin excretion. Br J Pharmacol Chemother. 1959 Mar;14(1):125–132. doi: 10.1111/j.1476-5381.1959.tb00938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MCCARTHY D. A., POTTER D. E., NICOLAIDES E. D. AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN. J Pharmacol Exp Ther. 1965 Apr;148:117–122. [PubMed] [Google Scholar]
  10. OATES J. A., MELMON K., SJOERDSMA A., GILLESPIE L., MASON D. T. RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet. 1964 Mar 7;1(7332):514–517. doi: 10.1016/s0140-6736(64)92907-1. [DOI] [PubMed] [Google Scholar]
  11. REGOLI D., VANE J. R. A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN. Br J Pharmacol Chemother. 1964 Oct;23:351–359. doi: 10.1111/j.1476-5381.1964.tb01591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SAAMELI K., ESKES T. K. Bradykinin and cardiovascular system: estimation of half-life. Am J Physiol. 1962 Aug;203:261–265. doi: 10.1152/ajplegacy.1962.203.2.261. [DOI] [PubMed] [Google Scholar]
  13. SCHACHTER M. A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin. Br J Pharmacol Chemother. 1956 Jun;11(2):111–118. doi: 10.1111/j.1476-5381.1956.tb01038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES